4-Hydroxybicyclo[2.2.2]octane-1-carbaldehyde, 95.0%, 50mg

Infinitely corrected plan PL 4x/0.10 IOS objective. Working distance 11.9 mm

(R)-tert-Butyl (1-cyclohexyl-2-hydroxyethyl)carbamate, 98.0%, 1g

(R)-2-(Boc-amino)-4-methyl-4-pentenoic acid, 98%, 500mg

(4-Benzylphenyl)boronic acid, 95.0%, 100mg

1-(2-Hydroxy-5-nitrophenyl)ethanone, 95.0%, 100g

(R)-4-Isopropyl-2-oxazolidinethione, 95%, 250mg

tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate, 95.0%, 5g

N,N-Dimethylglycine Ethyl Ester>98.0%(GC)500g

6-Chloro-3-cyclopropyl-[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 2.5g

tert-Butyl 1,8-diazaspiro[4.5]decane-8-carboxylate hydrochloride, 97%, 100mg

(S)-2-(4-Methoxyphenyl)pyrrolidine hydrochloride, 95.0%, 100mg

1-(2,2,2-TRIFLUOROACETAMIDO)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 250mg